Uptrend
Dist4
PHG

PHG

Koninklijke Philips NV ADR

$25.89-0.61%
Setup
No setup
Buy Zone
$26.42-$27.74
Sector
Medical Devices
Industry
Medical Devices
41
Recommendation
Avoid
Avoid

Too many CANSLIM criteria failing.

PHG chart

Loading chart…
ADX
Weak or Absent11.9
Long Term
Range
Intermediate Term
Range
Short Term
Range
Overall Quality41
27
relative strength
56
Weak fund-Q
45
-57% vs avg
25
2/8 checks
91
Medical Devices

Trade Plan

Avoid
Entry
$26.42
Entry Zone
$26.42-$27.74
Stop / Risk
$24.31
RS Rating
27
Volume confirmed
No
Targets
$31.7 / $33.03

Breakout · IBD Setup

2 6
Entry $26.42–$27.74Stop $24.31Target $31.7 / $33.03
Market regimeUptrend
Quality41
RS Rating27
Above 50-MA-3.56%
Above 200-MA-6.47%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop

How this came together

41
MarketUptrend
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q56 · Weak
StatusAvoid

Stock Data

52-Week Range24 – 33
Price % Chg YTD-4.39%
Price % Chg 4wk-1.67%
50-Day Avg Vol1.0 Mil
P/E Ratio19.3
Market Cap$25B
SectorHealthcare
IndustryMedical Devices

Company Fundamentals

EPS % Chg (Qtr)62.15%
Sales % Chg (Qtr)3.1%
EPS Growth 5y-4.98%
Sales Growth 5y0.39%
Annual ROE10.24%
Gross Margin45.93%
Operating Margin9.12%
Net Margin6.3%
Debt / Equity0.65

Setup levels

Current price
$25.89
Pivot
$26.42
Distance to buy
-22.6%
52-week range
23.85-33.44

Trigger evidence

No active trigger evidence available.
Financial health checks
3/5
Return on equity above 15%

ROE 10.24%

Net margin above 10%

Net margin 6.3%

EPS growing quarter on quarter

EPS q/q 62.15%

Sales growing quarter on quarter

Sales q/q 3.1%

Debt to equity below 1.0

D/E 0.65

Key metrics

Finviz snapshot · value vs. sector median (≥5 peers)

Annual ROE10.24%
vs sector -11.8%
Net margin6.3%
vs sector -10.7%
Gross margin45.93%
vs sector -20.7%
EPS growth q/q62.15%
vs sector +54.1%
Sales growth q/q3.1%
vs sector -15.4%
Debt / equity0.65
vs sector +0.01

Business quality

56
GradeWeak
EPS rating66
P/E19.3
Market cap$25B
IndustryMedical Devices

Technical checks

Über 50-MA
Fail
Über 200-MA
Fail
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Fail
Volumen gesund
Pass

IBD / source mentions

No recent IBD mention found for this ticker.

Signal history

Added to list
2026-08-29
Trigger date
Days on list
9

Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.